10 participants
GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-08-09
- Start Date:
- 2020-12-01
- Completion:
- 2022-06-30
Conditions
- Biliary Tract Carcinoma
Interventions
- COMBINATION_PRODUCT
No Results Yet